EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longevity Therapeutics: The Involvement of EDA2R, the “Self-Destruction Gene”

Renad I. Zhdanov, Nejat Düzgüneş

Therapeutics · 02.06.2026 · 3 (2) · 14

DOI: 10.3390/therapeutics3020014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutics, online erschienen am 02.06.2026. Verfasst von Renad I. Zhdanov und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma Ectodysplasin A2 Receptor (EDA2R) has emerged as one of the most robust tissue-agnostic biomarkers of biological aging, and importantly, appears to be causally involved in “inflammaging”—the chronic low-grade inflammation that drives age-related decline—rather than merely reflecting it [...]

Zitieren

APA

Zhdanov, R. I., & Düzgüneş, N. (2026). Longevity Therapeutics: The Involvement of EDA2R, the “Self-Destruction Gene”. Therapeutics, 3(2), 14. https://doi.org/10.3390/therapeutics3020014

Vancouver

Zhdanov RI, Düzgüneş N. Longevity Therapeutics: The Involvement of EDA2R, the “Self-Destruction Gene”. Therapeutics. 2026;3(2):14. doi:10.3390/therapeutics3020014

BibTeX
@article{Zhdanov2026,
  author = {Zhdanov, Renad I. and Düzgüneş, Nejat},
  title = {Longevity Therapeutics: The Involvement of EDA2R, the “Self-Destruction Gene”},
  journal = {Therapeutics},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {14},
  doi = {10.3390/therapeutics3020014}
}
Kostenlos starten →